Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-28

Clinical Trial Update: Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates oral tranexamic acid to reduce postoperative haemarthrosis after anterior cruciate ligament surgery, with status currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Liege | Conditions: Hemorrhage Postoperative, Anterior Cruciate Ligament Rupture | Phase 4 | Status: UNKNOWN